1Jennette.Nomenclature of systemic vasculitides.Proposal of an international consensus conference.Arthritis Rheum,1994,37:187
2Wen S F.Antineutrophil cytoplasmic autoantibodyassociated glomerulonephritis: potentially reversible disease.J Formos Med Assoc 1994,93(7):545
3De Bandt M.ANCA(antineutrophil cytoplasmic antibodies).Contribution of ANCA to the understanding of pathogenic mechanisms of systemic vasculitis.Ann Med Interne(Paris)1997,148(8):542
4Hattori M,Kurayama H,Koitabashi Y.Japanese Society for Pediatric Nephrology.Antineutrophil cytoplasmic autoantibodyassociated glomerulonephritis in children.J Am Soc Nephrol,2001,12(7):1493
5Rainer Nowack,Ursula Gobel,Pieter Klooker,et al.Mycophenolate Mofetil for Maintenance Therapy of Wegeners Granulomatosis and Microscopic Polyangiitis.J Am Soc Nephrol,1999,10(9):1965
6Nachman P H,Hogan S L,Jennette J C,et al.Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.J Am Soc Nephrol,1996,7(1):33
7Hogan S L,Nachman P H,Wilkman A S,et al.Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.J Am Soc Nephrol,1996,7(1):23
